Ligand Pharmaceuticals Incorporated

Healthcare · Biotechnology · United States

Last price 317.33 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.33B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteopor...